EcoDrugPlus

Serum Amyloid P-Component-Like

Ensembl ID : ENSBSLG00000014079
Gene Symbol: LOC114843124
2 Cross references
406 Possible Orthologues:

Si:dkey-211g8.6

Ensembl ID : ENSBSLG00000006022
Gene Symbol: SI:DKEY-211G8.6
1 Cross references
319 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSBSLG00000012113
Gene Symbol: SIGMAR1
3 Cross references
205 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSBSLG00000025890
Gene Symbol: SMO
3 Cross references
204 Possible Orthologues:

Sodium Channel Protein Type 4 Subunit Alpha B-Like

Ensembl ID : ENSBSLG00000023127
Gene Symbol: LOC114844814
3 Cross references
245 Possible Orthologues:

Sodium Channel Protein Type 4 Subunit Alpha-Like

Ensembl ID : ENSBSLG00000003139
Gene Symbol: LOC114853171
3 Cross references
246 Possible Orthologues:

Sodium Channel Protein Type 8 Subunit Alpha-Like

Ensembl ID : ENSBSLG00000007461
Gene Symbol: LOC114855143
2 Cross references
219 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 4

Ensembl ID : ENSBSLG00000017541
Gene Symbol: SCN4A
3 Cross references
187 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 8

Ensembl ID : ENSBSLG00000000742
Gene Symbol: SCN8A
3 Cross references
218 Possible Orthologues:

Sodium- And Chloride-Dependent Gaba Transporter 1-Like

Ensembl ID : ENSBSLG00000011021
Gene Symbol: LOC114858283
3 Cross references
204 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSBSLG00000015126
Gene Symbol: LOC114866788
3 Cross references
249 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSBSLG00000015951
Gene Symbol: LOC114866860
3 Cross references
249 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).